Metra plans to slash costs while seeking new partnerships
This article was originally published in Clinica
Metra Biosystems has announced a plan to significantly reduce its operating expenses next year. The move follows an already reduced cash burn in fiscal 1998 and the company is optimistic that its partnerships with major companies will prompt increased revenue next year. At the end of the last financial year the company had +ACQ-27 million and last year turned in net losses of +ACQ-12 million.